⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2323258 | 0.69 | — | — | |
| SCHEMBL6551747 | 0.67 | — | — | |
| SCHEMBL8394559 | 0.67 | — | — | |
| SCHEMBL4639871 | 0.63 | — | — | |
| SCHEMBL1811895 | 0.61 | — | — | |
| SCHEMBL5711539 | 0.60 | — | — | |
| SCHEMBL10912484 | 0.58 | — | — | |
| SCHEMBL10771052 | 0.57 | — | — | |
| SCHEMBL8491703 | 0.57 | — | — | |
| SCHEMBL220417 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1012139-B1 | AZETIDINONE DERIVATIVES AS BETA-LACTAMASE INHIBITORS | NAEJA PHARMACEUTICAL INC (CA) | 2002-11-13 | — | — | EP | disclosed |
| EP-1012139-A4 | AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS | NAEJA PHARMACEUTICAL INC (CA) | 2001-08-16 | — | — | EP | disclosed |
| EP-1012139-A1 | AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS | Naeja Pharmaceutical Inc. (CA) | 2000-06-28 | — | — | EP | disclosed |
| WO-1999010324-A1 | AZETIDINONE DERIVATIVES AS β-LACTAMASE INHIBITORS | NAEJA PHARMACEUTICAL INC. (CA) | 1999-03-04 | — | — | WO | disclosed |